- Motley Fool•11 days ago
Idera's recent shuffling of its pipeline priorities calls into question just how much potential its drug candidates actually have.
- 24/7 Wall St.•12 days ago
The late-summer doldrums are over and the markets are on the move again as we are now in the fourth quarter. But a few companies held the market back from pushing even higher.
Idera Pharmaceuticals, Inc. (IDRA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||1.89 x 1100|
|Ask||1.95 x 3500|
|Day's Range||1.65 - 2.02|
|52wk Range||1.19 - 4.42|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.59|
|Avg Vol (3m)||1,175,110|
|Dividend & Yield||N/A (N/A)|